Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (251-260 of 284) with videos related to

Pageof 29
Sort By:
Science Translational Medicine|September 10, 2020
Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockadeLiangliang Wang, Yan Gao, Gao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionWei Li, Chuan Chen, Aleksandra Drelich, et al.
Science (New York, N.Y.)|December 8, 2009
Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120Lei Chen, Young Do Kwon, Tongqing Zhou, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Nature Communications|August 18, 2022
SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralizationDhiraj Mannar, James W Saville, Zehua Sun, et al.
Nature Communications|November 18, 2022
Cancer cell survival depends on collagen uptake into tumor-associated stromaKuo-Sheng Hsu, James M Dunleavey, Christopher Szot, et al.
Cell Host & Microbe|October 3, 2017
A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza HemagglutininFei Yu, He Song, Yanling Wu, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Pageof 29

Showing results (251-260 of 284) with videos related to

Sort By:
Pageof 29
Science Translational Medicine|September 10, 2020
Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockadeLiangliang Wang, Yan Gao, Gao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2007
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesZhongyu Zhu, Samitabh Chakraborti, Yuxian He, et al.
Cell Reports. Medicine|August 2, 2021
A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitopeSwetha Raman, Samantha N Buongervino, Maria V Lane, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionWei Li, Chuan Chen, Aleksandra Drelich, et al.
Science (New York, N.Y.)|December 8, 2009
Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120Lei Chen, Young Do Kwon, Tongqing Zhou, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Nature Communications|August 18, 2022
SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralizationDhiraj Mannar, James W Saville, Zehua Sun, et al.
Nature Communications|November 18, 2022
Cancer cell survival depends on collagen uptake into tumor-associated stromaKuo-Sheng Hsu, James M Dunleavey, Christopher Szot, et al.
Cell Host & Microbe|October 3, 2017
A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza HemagglutininFei Yu, He Song, Yanling Wu, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Pageof 29